[go: up one dir, main page]

FI911875L - Kirala 2-(fosfonometoxi) propylguaniner som antivirala aemnen. - Google Patents

Kirala 2-(fosfonometoxi) propylguaniner som antivirala aemnen. Download PDF

Info

Publication number
FI911875L
FI911875L FI911875A FI911875A FI911875L FI 911875 L FI911875 L FI 911875L FI 911875 A FI911875 A FI 911875A FI 911875 A FI911875 A FI 911875A FI 911875 L FI911875 L FI 911875L
Authority
FI
Finland
Prior art keywords
propylguaniner
phosphonomethoxi
kirala
antivirala
aemnen
Prior art date
Application number
FI911875A
Other languages
English (en)
Other versions
FI911875A0 (fi
FI911875A7 (fi
Inventor
Kuo-Long Yu
Joanne J Bronson
John C Martin
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI911875A0 publication Critical patent/FI911875A0/fi
Publication of FI911875L publication Critical patent/FI911875L/fi
Publication of FI911875A7 publication Critical patent/FI911875A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI911875A 1990-04-20 1991-04-18 Kiraaliset 2-(fosfonometoksi)propyyliguaniinit virustenvastaisina aineina FI911875A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51169090A 1990-04-20 1990-04-20
US51330790A 1990-04-20 1990-04-20

Publications (3)

Publication Number Publication Date
FI911875A0 FI911875A0 (fi) 1991-04-18
FI911875L true FI911875L (fi) 1991-10-21
FI911875A7 FI911875A7 (fi) 1991-10-21

Family

ID=27057310

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911875A FI911875A7 (fi) 1990-04-20 1991-04-18 Kiraaliset 2-(fosfonometoksi)propyyliguaniinit virustenvastaisina aineina

Country Status (10)

Country Link
EP (1) EP0452935B1 (fi)
JP (1) JP3172801B2 (fi)
KR (1) KR100188554B1 (fi)
AT (1) ATE124050T1 (fi)
AU (1) AU643987B2 (fi)
CA (1) CA2040854C (fi)
DE (1) DE69110528T2 (fi)
FI (1) FI911875A7 (fi)
IE (1) IE68415B1 (fi)
PT (1) PT97407B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001698A1 (en) * 1990-07-19 1992-02-06 Beecham Group Plc Antiviral phosphono-alken derivatives of purines
WO1993006112A1 (en) * 1991-09-24 1993-04-01 The Wellcome Foundation Limited Therapeutic nucleosides
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
GB9226879D0 (en) * 1992-12-23 1993-02-17 Iaf Biochem Int Anti-viral compounds
US6444656B1 (en) 1992-12-23 2002-09-03 Biochem Pharma, Inc. Antiviral phosphonate nucleotides
US6005107A (en) * 1992-12-23 1999-12-21 Biochem Pharma, Inc. Antiviral compounds
US5877166A (en) * 1996-04-29 1999-03-02 Sri International Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents
ES2536972T5 (es) * 2000-07-21 2022-04-06 Gilead Sciences Inc Profármacos de análogos de nucleótidos de fosfonato y métodos para seleccionar y preparar los mismos
EP3578563B1 (en) 2011-12-22 2021-04-14 Geron Corporation Guanine analogs as telomerase substrates and telomere length affectors
KR200488845Y1 (ko) * 2019-03-12 2019-07-31 임병철 엔진 구동 교육 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
IL84477A (en) * 1986-11-18 1995-12-08 Bristol Myers Squibb Co History of Phosphonomethoxyalkylene Purinopyrimidine and Pharmaceutical Preparations Containing Them

Also Published As

Publication number Publication date
CA2040854A1 (en) 1991-10-21
AU643987B2 (en) 1993-12-02
ATE124050T1 (de) 1995-07-15
DE69110528T2 (de) 1996-03-14
EP0452935A1 (en) 1991-10-23
IE911321A1 (en) 1991-10-23
PT97407B (pt) 1998-08-31
AU7517191A (en) 1991-10-24
FI911875A0 (fi) 1991-04-18
PT97407A (pt) 1992-01-31
KR910018393A (ko) 1991-11-30
EP0452935B1 (en) 1995-06-21
CA2040854C (en) 2000-11-21
JP3172801B2 (ja) 2001-06-04
DE69110528D1 (de) 1995-07-27
FI911875A7 (fi) 1991-10-21
KR100188554B1 (ko) 1999-06-01
JPH0539297A (ja) 1993-02-19
IE68415B1 (en) 1996-06-12

Similar Documents

Publication Publication Date Title
FI914619A7 (fi) Hydroxylfunktionaliserade polyeteraminer som barriaerfoerpackning foer syrekaensliga materialer.
FI914796L (fi) Omaettade hydroxialkylkinolinsyror som leukotrienantagonister.
FI914596L (fi) Biaxialt orienterad polypropylenfolie avsedd som foerpackningsomslag.
FI910993A7 (fi) Hjaelpmedel som foerbaettrar glidegenskaper.
FI931367L (fi) Tvaettmedelskompositioner, som innehaoller polyhydroxifettsyraamider ochen skumfoerstaerkare
FI913738A7 (fi) Oximkarbamater och oximkarbonater som luftroersutvidgande och antiinflammatoriska aemnen.
FI915357A0 (fi) Optisk bakskiva som foerbinder kretskort.
FI914004A0 (fi) Epoxifunktionella siloxanhartskopolymerer som loesgoeringsreglerande tillaeggsaemnen.
FI913215A0 (fi) Additionspolymeriseringskatalysator, som aktiveras medelst oxidering.
FI921182A0 (fi) Velangummi som snabbt hydratiseras.
FI914797A0 (fi) Maettade hydroxialkylkinolinsyror som leukotrienantagonister.
FI920271L (fi) Polyamintioler som straolningsskyddande aemnen.
FI912468L (fi) Oxidantkaensliga och -okaensliga aromatiska estrar som inhibitorer foer humant neutrofilelastas.
FI910572A7 (fi) Regnmaetare med anordning som paovisar tilltaeppning.
FI915568L (fi) Polyamidhartskompositioner foer anvaendning som bindemedel foer laminerande tryckfaergshartser.
FI910425L (fi) Di- och tetrafluoranaloger av skvalen som skvalenepoxidas-inhibitorer.
FI923367L (fi) Molekyler med antikroppkombinations- staellen som katalyserar hydrolysreaktioner.
FI914201L (fi) Anvaendning av staerkelseblandningar som puddingstaerkelse.
FI911875L (fi) Kirala 2-(fosfonometoxi) propylguaniner som antivirala aemnen.
FI913657A7 (fi) 4-amino-d4-steroider och deras anvaendning som 5a-reduktasinhibitorer.
FI912287L (fi) Anvaendning av heminnehaollande proteiner som stabilisatorer foer enzymmaerkta immunreaktanter.
FI911720L (fi) Anvaendning av makrocykliska foereningar som komponenter foer ferroelektriska vaetskekristallblandningar.
FI914795L (fi) Hydroxialkylkinolinetersyror som leukotrienantagonister.
FI932654L (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
FI932873A7 (fi) D-homo-(16-en)-11b-aryl-4-estrener, foerfarande foer deras framstaellningoch deras anvaendning som laekemedel

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: INSTITUTE OF ORGANIC CHEMISTRY AND

FD Application lapsed